Only 10% of global health research serves the 90% who carry the heaviest burden of disease.
We’re an interdisciplinary collective of clinicians and student researchers focusing on proactive biology over reactive technology. This year in Rio de Janeiro, we’re addressing the convergence of visceral leishmaniasis and HIV before an outbreak forces it.
With each finding, we get closer to making the 10/90 gap impossible.
See our researchImplications for outbreak surveillance.
A systematic review examining whether visceral leishmaniasis (VL) tends to present and be diagnosed earlier among people living with HIV than in HIV-negative populations — and whether that timing could help surface outbreaks sooner. The work explores how existing HIV surveillance infrastructure might serve as an early signal for VL outbreak detection in endemic settings.
Full results, effect sizes, and the accompanying geospatial modelling demo are embargoed until presentation at AIDS 2026.